# The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

> **NCT04349826** · PHASE4 · COMPLETED · sponsor: **Oxford University Clinical Research Unit, Vietnam** · enrollment: 2150 (actual)

## Conditions studied

- Typhoid Fever

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Cefixime
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04349826
- **Lead sponsor:** Oxford University Clinical Research Unit, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-23
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 2150 (ACTUAL)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349826, "The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04349826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*